Annual report [Section 13 and 15(d), not S-K Item 405]

SEGMENT INFORMATION (Tables)

v3.25.0.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2024
SEGMENT INFORMATION  
Schedule of segment information

Year Ended December 31,

 

2024

    

2023

    

2022

(in thousands)

Total Revenues

$

179,278

$

116,882

$

120,242

Less:

Employee related expenses

69,807

63,429

69,477

Commercial related expenses

26,996

24,310

23,846

Cost of product sales

18,647

7,110

1,749

Consultants and third-party services

15,532

17,942

22,218

Outside clinical trial related expenses

10,978

9,694

29,981

Other segment items

13,126

14,888

28,521

Interest expense, net

5,826

4,600

3,023

Provision for income taxes

881

Segment income (loss)

$

17,485

$

(25,091)

$

(58,573)